AUTH/2484/2/12: Therapist v Sanofi (Clexane) — medical information request from member of the public (No breach)

📅 2012 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2484/2/12
PartiesTherapist v Sanofi
ProductClexane (enoxaparin)
IssueAlleged obstruction/refusal to provide information about timing of injection prior to a long flight (personal medical enquiry)
Applicable Code year2011
Clauses considered9.1, 22.2, 22.3
Panel decisionNo breach of the Code
Complaint received29 February 2012
Case completed11 April 2012
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A clinical hypnotherapist/psychoanalyst/behavioural therapist phoned Sanofi’s medical information department about his possible personal use of Clexane (enoxaparin) before a nine-hour flight (and long car journeys).
  • He asked how long before travel he should inject Clexane and said Sanofi had “lots of data” but would not share it with him.
  • He said his GP and pharmacist “had no idea what time parameter to use” and that being told to have his doctor call was difficult.
  • Sanofi explained the SPC did not include a dosing regimen for prevention of in-flight thrombosis and that Clexane did not appear indicated for that circumstance.
  • Sanofi told the caller it could not comment on his personal medical situation and advised him to consult his own doctor or pharmacist; it offered to provide information to the doctor/pharmacist if they contacted Sanofi directly.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel found Sanofi handled a personal medical enquiry appropriately by referring the caller back to a health professional and not providing product use information to the caller.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training